SENORES PHARMACEUTICALS LIMITE - Share Price & Details
High price all time
719.0
Peer Comparison
About SENORES PHARMACEUTICALS LIMITE
Company Updates
Quarterly Table
Metrics | Dec 2024 | Mar 2025 |
---|
Sales | 9.6 | 11.9 |
---|
Expenses | 12.0 | 14.6 |
---|
Operating Profit | -2.4 | -2.7 |
---|
OPM % | -25.11% | -22.93% |
---|
Other Income | 7.2 | 9.3 |
---|
Interest | 2.7 | 2.4 |
---|
Depreciation | 0.8 | 1.3 |
---|
Profit before tax | 1.3 | 2.9 |
---|
Tax % | -18.6% | -27.6% |
---|
Net Profit | 1.1 | 2.0 |
---|
EPS in Rs | 0.32 | 0 |
---|
Metrics | Dec 2024 | Mar 2025 | Jun 2025 |
---|
Sales | 103.0 | 114.2 | 138.0 |
---|
Expenses | 77.3 | 94.8 | 103.8 |
---|
Operating Profit | 25.7 | 19.4 | 34.2 |
---|
OPM % | 24.93% | 17.02% | 24.76% |
---|
Other Income | 5.2 | 11.8 | 3.4 |
---|
Interest | 6.2 | 5.3 | 5.0 |
---|
Depreciation | 4.2 | 5.2 | 6.0 |
---|
Profit before tax | 20.5 | 20.7 | 26.5 |
---|
Tax % | 19.8% | -13.1% | 20% |
---|
Net Profit | 16.4 | 18.0 | 21.2 |
---|
EPS in Rs | 5.04 | 0 | 4.6 |
---|
Shareholding Distribution
Shareholding Pattern
Compounded Data
Compounded Sales
Growth |
10 Years: |
0% |
5 Years: |
0% |
3 Years: |
42% |
TTM: |
13% |
Compounded Profit
Growth |
10 Years: |
0% |
5 Years: |
0% |
3 Years: |
76% |
TTM: |
356% |
Stock Price CAGR |
10 Years: |
0% |
5 Years: |
0% |
3 Years: |
0% |
1 Year: |
0% |
Compounded Sales
Growth |
10 Years: |
0% |
5 Years: |
0% |
3 Years: |
204% |
TTM: |
86% |
Compounded Profit
Growth |
10 Years: |
0% |
5 Years: |
0% |
3 Years: |
289% |
TTM: |
85% |
Stock Price CAGR |
10 Years: |
0% |
5 Years: |
0% |
3 Years: |
0% |
1 Year: |
0% |